Related Experiment Video
Updated: Jun 21, 2025
Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
ROS induced pyroptosis in inflammatory disease and cancer
Jingsong Wang1, Ziyong Wu2, Min Zhu3
1Department of Pharmacy, Guangyuan Central Hospital, Guangyuan, Sichuan, China.
Abstract:
Pyroptosis, a form of caspase-1-dependent cell death, also known as inflammation-dependent death, plays a crucial role in diseases such as stroke, heart disease, or tumors. Since its elucidation, pyroptosis has attracted widespread attention from various sectors. Reactive oxygen species (ROS) can regulate numerous cellular signaling pathways. Through further research on ROS and pyroptosis, the level of ROS has been revealed to be pivotal for the occurrence of pyroptosis, establishing a close relationship between the two. This review primarily focuses on the molecular mechanisms of ROS and pyroptosis in tumors and inflammatory diseases, exploring key proteins that may serve as drug targets linking ROS and pyroptosis and emerging fields targeting pyroptosis. Additionally, the potential future development of compounds and proteins that influence ROS-regulated cell pyroptosis is anticipated, aiming to provide insights for the development of anti-tumor and anti-inflammatory drugs.
Insights
Reactive oxygen species (ROS) are pivotal in pyroptosis, an inflammatory cell death crucial for diseases like cancer. Understanding ROS-regulated pyroptosis offers new avenues for anti-tumor and anti-inflammatory drug development.
Area of Science:
- Cellular biology
- Molecular mechanisms
- Disease pathology
Background:
- Pyroptosis, or inflammation-dependent cell death, is a key process in diseases including stroke, heart disease, and tumors.
- Reactive oxygen species (ROS) significantly influence cellular signaling pathways.
- A strong link exists between ROS levels and the occurrence of pyroptosis.
Purpose of the Study:
- To review the molecular mechanisms of ROS and pyroptosis in cancer and inflammatory diseases.
- To identify potential drug targets linking ROS and pyroptosis.
- To explore emerging therapeutic strategies for pyroptosis-related diseases.
Main Methods:
- Literature review focusing on molecular mechanisms.
- Analysis of key proteins involved in ROS-regulated pyroptosis.
- Exploration of current and future therapeutic interventions.
Main Results:
- ROS levels are critical regulators of pyroptosis.
- Specific proteins mediating ROS-pyroptosis interactions are identified as potential drug targets.
- Targeting pyroptosis presents a promising strategy for treating inflammatory diseases and tumors.
Conclusions:
- The intricate relationship between ROS and pyroptosis is central to understanding inflammatory diseases and cancer.
- Developing drugs that modulate ROS-regulated pyroptosis holds significant therapeutic potential.
- Further research into targeting pyroptosis could lead to novel anti-cancer and anti-inflammatory therapies.
